Alberto Pappo
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alberto Pappo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:20 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06023641 · Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk DiseaseSt. Jude Children's Research Hospital · recruiting · Rhabdomyosarcoma · principal investigator
- N/ANCT03276702 · Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid MalignanciesSt. Jude Children's Research Hospital · completed · Tumor, Solid · principal investigator
- N/ANCT02775643 · Molecular Analysis of Childhood and Adolescent Melanocytic LesionsSt. Jude Children's Research Hospital · recruiting · Melanoma · principal investigator
- Ph2NCT00539591 · Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk MelanomaSt. Jude Children's Research Hospital · active not recruiting · Malignant Melanoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:20 UTC. The ranking covers the 200 most relevant of 52 PubMed records, and a shared surname and initials can bring in a namesake. All 52 on PubMed
- 2,232 citationsRCR 80.0
- Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.Lancet Oncol · 2020856 citationsRCR 36.6
- Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.Lancet Oncol · 2018463 citationsRCR 15.8
- 356 citationsRCR 8.4
- 286 citationsRCR 7.3
- Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.J Clin Oncol · 2006284 citationsRCR 6.8
- 279 citationsRCR 10.9
- Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children.J Clin Oncol · 1999190 citationsRCR 4.4
- A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.Pediatr Blood Cancer · 2008168 citationsRCR 4.0
- 167 citationsRCR 5.0